Inventurus Knowledge Solutions Ltd

Inventurus Knowledge Solutions has approved grant of 75,000 employee stock options under the IKS ESOP Plan on 20 February 2026. Powered by Capital Market - Live

Profit before tax (PBT) climbed 43.22% YoY to Rs 229.37 crore in Q3 FY26. EBITDA jumped 40% to Rs 281.6 crore in Q3 FY26, registering the growth of 40% compared with Rs 271.8 crore in Q3 FY25.EBITDA margin improved to 34.6% in Q3 FY26 as against 30.5% in Q3 FY25. Sachin K. Gupta, founder & Global CEO, IKS Health,said, 'Our strong Q3 performance, characterized by 24% revenue growth, validatesthat our Care Enablement Platform is the critical solution for a US healthcare market facing a perfect storm of cost, quality, and access pressures. As physician marginsface renewed compression from stagnant reimbursement rates, we are seeing this act as a powerful catalyst for increased outsourcing and platform adoption. We continue to deepen our value proposition by advancing our AI capabilities'specifically moving our Patient Engagement suite toward multi-agent orchestration'to drive cognitive reasoning and independent action. Our recent wins with partners like StrideCare and VitalMD demonstrate that provider enterprises are increasingly choosing our integrated platform to ensure their financial sustainability and clinical efficiency.' Nithya Balasubramanian, Group CFO, IKS Health said, 'Our Q3 FY2026 performance underscores our consistent ability to drive profitable growth and deliver significant value to our clients. We achieved a 24% year-on-year revenue increase and a 41% growth in Profit After Tax (PAT), fueled by continuous expansion across existing and new client relationships. Margin expansion is a direct result of our successful operating leverage, technology deployment and focused cost management. ' Inventurus Knowledge Solutions (IKS Health) is a leading technology enabled healthcare solutions provider, primarily serving the US healthcare market. It offers a comprehensive care enablement platform that supports healthcare enterprises across outpatient and inpatient care settings.Powered by Capital Market - Live

Net profit of Inventurus Knowledge Solutions rose 41.37% to Rs 183.33 crore in the quarter ended December 2025 as against Rs 129.68 crore during the previous quarter ended December 2024. Sales rose 24.01% to Rs 814.95 crore in the quarter ended December 2025 as against Rs 657.16 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales814.95657.16 24 OPM %34.2627.61 - PBDT261.42187.91 39 PBT229.37160.16 43 NP183.33129.68 41 Powered by Capital Market - Live

Inventurus Knowledge Solutions will hold a meeting of the Board of Directors of the Company on 4 February 2026.Powered by Capital Market - Live

Inventurus Knowledge Solutions has allotted 4,70,000 equity shares under the IKS ESOP Plan on 04 December 2025.Powered by Capital Market - Live

Inventurus Knowledge Solutions announced the inauguration of its new office in Coimbatore today. The 1000-seat, state-of-the-art facility is designed to accommodate the rapid expansion of IKS Health's operations for the US Healthcare market. This new office is slated to become a significant talent hub, generating employment for recent university graduates, as well as experienced professionals with backgrounds in medicine, pharmacy, technology, and engineering. Nithya Balasubramanian, Whole-time Director & CFO, IKS Health said, 'Our second quarter performance for Fiscal Year 2026 demonstrates our commitment to consistent, profitable growth, evidenced by a 22% year-over-year growth in revenue, and a 60% rise in Profit After Tax (PAT). This sustained momentum is fundamentally driven by our talented workforce. The strategic expansion of our local talent base in Coimbatore is crucial, as it enhances our capacity for execution excellence and allows us to vigorously pursue our long-term objectives of enabling better, safer healthcare in the US market.' Powered by Capital Market - Live

Profit before tax (PBT) climbed 58.5% YoY to Rs 227.71 crore in Q2 FY26. EBITDA stood at Rs 271.8 crore, up 43% compared with Rs 189.8 crore posted in corresponding quarter last year. EBITDA margin improved to 34.8% in Q2 FY26 as against 29.5% in Q2 FY25. Sachin K. Gupta, Founder & Global CEO, IKS Health, said, 'The second quarter was a period of significant strategic execution and strong financial performance for IKS Health. Our results underscore the growing market demand for our Care Enablement Platform as health systems increasingly recognize the need to holistically address administrative, clinical, and financial challenges. A key highlight of this quarter was the launch of our Agentic AI platform on Google Cloud and native integration of Scribble Now, our ambient AI scribing solution, into revenue cycle management, coding, and clinical documentation workflows, creating the industry's first connected encounter-to-reimbursement platform and winning the 2025 Dora Award from Google Cloud Award for 'Augmenting Human Expertise with AI'. We have also significantly accelerated the execution of our AI strategy, marked by the appointment of our new Chief AI Officer. These accomplishments reflect our unwavering commitment to augmenting human expertise to deliver unparalleled clinical, financial, and operational excellence to our clients. Nithya Balasubramanian, Group CFO, IKS Health said, 'IKS Health's strong Q2 FY26 financial performance, highlighted by a 22% year-over-year Revenue, 43% EBITDA and 60% PAT growth reflects our continued focus on driving consistent, profitable growth. The improvement in our EBITDA margin showcases the scalability of our platform and disciplined capital management. ' Inventurus Knowledge Solutions (IKS Health) is a leading technology enabled healthcare solutions provider, primarily serving the US healthcare market. It offers a comprehensive care enablement platform that supports healthcare enterprises across outpatient and inpatient care settings.Powered by Capital Market - Live

Net profit of Inventurus Knowledge Solutions rose 59.93% to Rs 180.72 crore in the quarter ended September 2025 as against Rs 113.00 crore during the previous quarter ended September 2024. Sales rose 21.52% to Rs 781.09 crore in the quarter ended September 2025 as against Rs 642.78 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales781.09642.78 22 OPM %34.6129.42 - PBDT257.85172.03 50 PBT227.71143.70 58 NP180.72113.00 60 Powered by Capital Market - Live

Inventurus Knowledge Solutions has made further investment of USD 10,001,605/- in Inventurus Knowledge Solutions, Inc. (IKS Inc), a wholly owned subsidiary of the Company. Powered by Capital Market - Live

Inventurus Knowledge Solutions has granted 90,000 stock options under ESOP. Powered by Capital Market - Live